155 related articles for article (PubMed ID: 22974970)
21. A mathematical model of doxorubicin penetration through multicellular layers.
Evans CJ; Phillips RM; Jones PF; Loadman PM; Sleeman BD; Twelves CJ; Smye SW
J Theor Biol; 2009 Apr; 257(4):598-608. PubMed ID: 19183560
[TBL] [Abstract][Full Text] [Related]
22. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice.
Cemazar M; Parkins CS; Holder AL; Kranjc S; Chaplin DJ; Sersa G
Anticancer Res; 2001; 21(2A):1151-6. PubMed ID: 11396155
[TBL] [Abstract][Full Text] [Related]
24. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
Harting C; Peschke P; Borkenstein K; Karger CP
Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
[TBL] [Abstract][Full Text] [Related]
25. Optimising non-viral gene delivery in a tumour spheroid model.
Mellor HR; Davies LA; Caspar H; Pringle CR; Hyde SC; Gill DR; Callaghan R
J Gene Med; 2006 Sep; 8(9):1160-70. PubMed ID: 16807955
[TBL] [Abstract][Full Text] [Related]
26. [Multicellular resistance: another mechanisms of pleiotropic resistance?].
Desoize B; Gimonet D; Jardillier JC
Bull Cancer; 1998 Sep; 85(9):785-93. PubMed ID: 9817062
[TBL] [Abstract][Full Text] [Related]
27. The role of acidity in solid tumour growth and invasion.
Smallbone K; Gavaghan DJ; Gatenby RA; Maini PK
J Theor Biol; 2005 Aug; 235(4):476-84. PubMed ID: 15935166
[TBL] [Abstract][Full Text] [Related]
28. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice.
Olive PL; Vikse CM; Banath JP
Cancer Res; 1996 Oct; 56(19):4460-3. PubMed ID: 8813141
[TBL] [Abstract][Full Text] [Related]
29. Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation.
Govaert KM; Nijkamp MW; Emmink BL; Steller EJ; Minchinton AI; Kranenburg O; Borel Rinkes IH
Br J Surg; 2012 Apr; 99(4):567-75. PubMed ID: 22331808
[TBL] [Abstract][Full Text] [Related]
30. Modelling the formation of necrotic regions in avascular tumours.
Tindall MJ; Please CP; Peddie MJ
Math Biosci; 2008 Jan; 211(1):34-55. PubMed ID: 18082225
[TBL] [Abstract][Full Text] [Related]
31. Formulation and numerical simulations of a continuum model of avascular tumor growth.
Mahmood MS; Mahmood S; Dobrota D
Math Biosci; 2011 Jun; 231(2):159-71. PubMed ID: 21396381
[TBL] [Abstract][Full Text] [Related]
32. Coupled modelling of tumour angiogenesis, tumour growth and blood perfusion.
Cai Y; Xu S; Wu J; Long Q
J Theor Biol; 2011 Jun; 279(1):90-101. PubMed ID: 21392511
[TBL] [Abstract][Full Text] [Related]
33. Cellular automata coupled with steady-state nutrient solution permit simulation of large-scale growth of tumours.
Shrestha SM; Joldes GR; Wittek A; Miller K
Int J Numer Method Biomed Eng; 2013 Apr; 29(4):542-59. PubMed ID: 23382053
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids.
Lobjois V; Frongia C; Jozan S; Truchet I; Valette A
Eur J Cancer; 2009 Sep; 45(13):2402-11. PubMed ID: 19553104
[TBL] [Abstract][Full Text] [Related]
35. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
Karlsson H; Fryknäs M; Larsson R; Nygren P
Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia--a key regulatory factor in tumour growth.
Harris AL
Nat Rev Cancer; 2002 Jan; 2(1):38-47. PubMed ID: 11902584
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic/pharmacodynamic model-guided identification of hypoxia-selective 1,2,4-benzotriazine 1,4-dioxides with antitumor activity: the role of extravascular transport.
Hay MP; Hicks KO; Pruijn FB; Pchalek K; Siim BG; Wilson WR; Denny WA
J Med Chem; 2007 Dec; 50(25):6392-404. PubMed ID: 18001018
[TBL] [Abstract][Full Text] [Related]
38. Asymmetric growth of models of avascular solid tumours: exploiting symmetries.
Byrne H; Matthews P
IMA J Math Appl Med Biol; 2002 Mar; 19(1):1-29. PubMed ID: 12408222
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides: the influence of hydrogen bond donors on extravascular transport and antitumor activity.
Hay MP; Pchalek K; Pruijn FB; Hicks KO; Siim BG; Anderson RF; Shinde SS; Phillips V; Denny WA; Wilson WR
J Med Chem; 2007 Dec; 50(26):6654-64. PubMed ID: 18052317
[TBL] [Abstract][Full Text] [Related]
40. Endogenous and induced oxidative stress in multi-cellular tumour spheroids: implications for improving tumour therapy.
Khaitan D; Dwarakanath BS
Indian J Biochem Biophys; 2009 Feb; 46(1):16-24. PubMed ID: 19374249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
